Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
275.25%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 0.46Close
$ 0.41 - $ 3.18 52-Week Range
Ticker Information
Ticker
RANICompany Name
RANI THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRANI THERAPEUTICS HOLDINGS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RANI - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.3M | 275.25% | $ 1.2M |
| 3/31/2025 | $ 2.94M | 244.92% | $ 1.2M |
| 12/31/2024 | $ 2.84M | 275.97% | $ 1.03M |
| 9/30/2024 | $ 2.58M | 0% | $ 0 |
| 6/30/2024 | $ 1.95M | 0% | $ 0 |
| 3/31/2024 | $ 2.04M | 0% | $ 0 |
| 12/31/2023 | $ 1.86M | 0% | $ 0 |
| 9/30/2023 | $ 1.78M | 0% | $ 0 |
| 6/30/2023 | $ 1.66M | 0% | $ 0 |
| 3/31/2023 | $ 1.49M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- RANI THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) DepAmor % stands at 127.49%.
- Over the past 5 years, RANI THERAPEUTICS HOLDINGS INC's average DepAmor % has been 162.33%.
- The median DepAmor % for RANI THERAPEUTICS HOLDINGS INC during this period was 186.2%
- RANI THERAPEUTICS HOLDINGS INC reached its highest DepAmor % over the past 5 years at 275.97%.
- The lowest DepAmor % recorded by RANI THERAPEUTICS HOLDINGS INC in the same timeframe 18.29%
RANI THERAPEUTICS HOLDINGS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for RANI THERAPEUTICS HOLDINGS INC is calculated as follows: DepAmor [ $ 589K ] / Revenues [ $ 462K ]
(=) DepAmor % [ 127.49% ] RANI - Depreciation and Amortization Margin, Last 5 years
18.29%
Minimum
Dec 31, 2021
275.97%
Maximum
Dec 31, 2024
162.33%
Average
186.2%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |